These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22343944)

  • 1. Cholesterol loss during glutamate-mediated excitotoxicity.
    Sodero AO; Vriens J; Ghosh D; Stegner D; Brachet A; Pallotto M; Sassoè-Pognetto M; Brouwers JF; Helms JB; Nieswandt B; Voets T; Dotti CG
    EMBO J; 2012 Apr; 31(7):1764-73. PubMed ID: 22343944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro.
    Sodero AO; Weissmann C; Ledesma MD; Dotti CG
    Neurobiol Aging; 2011 Jun; 32(6):1043-53. PubMed ID: 20663588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
    Fourgeux C; Martine L; Acar N; Bron AM; Creuzot-Garcher CP; Bretillon L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):775-81. PubMed ID: 24491555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxysterols in the brain of the cholesterol 24-hydroxylase knockout mouse.
    Meljon A; Wang Y; Griffiths WJ
    Biochem Biophys Res Commun; 2014 Apr; 446(3):768-74. PubMed ID: 24491562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate affects cholesterol homeostasis within the brain via the up-regulation of CYP46A1 and ApoE.
    Zhang J; Zhang F; Wu J; Li J; Yang Z; Yue J
    Toxicology; 2020 Feb; 432():152381. PubMed ID: 31981724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma.
    Fourgeux C; Bron A; Acar N; Creuzot-Garcher C; Bretillon L
    Chem Phys Lipids; 2011 Sep; 164(6):496-9. PubMed ID: 21531213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
    Tian G; Kong Q; Lai L; Ray-Chaudhury A; Lin CL
    J Neurochem; 2010 May; 113(4):978-89. PubMed ID: 20193040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury.
    He X; Jenner AM; Ong WY; Farooqui AA; Patel SC
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):652-63. PubMed ID: 16825952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium influx constitutes the ionic basis for the maintenance of glutamate-induced extended neuronal depolarization associated with hippocampal neuronal death.
    Limbrick DD; Sombati S; DeLorenzo RJ
    Cell Calcium; 2003 Feb; 33(2):69-81. PubMed ID: 12531183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina.
    Bretillon L; Diczfalusy U; Björkhem I; Maire MA; Martine L; Joffre C; Acar N; Bron A; Creuzot-Garcher C
    Curr Eye Res; 2007 Apr; 32(4):361-6. PubMed ID: 17453958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices.
    Sun MY; Izumi Y; Benz A; Zorumski CF; Mennerick S
    J Neurophysiol; 2016 Mar; 115(3):1263-72. PubMed ID: 26745248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
    Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
    Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
    J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chandipura virus perturbs cholesterol homeostasis leading to neuronal apoptosis.
    Ghosh S; Mukherjee S; Basu A
    J Neurochem; 2015 Oct; 135(2):368-80. PubMed ID: 26118540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels.
    Peña F; Tapia R
    Neuroscience; 2000; 101(3):547-61. PubMed ID: 11113304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
    Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
    Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination.
    Milagre I; Nunes MJ; Moutinho M; Rivera I; Fuso A; Scarpa S; Gama MJ; Rodrigues E
    J Alzheimers Dis; 2010; 22(4):1209-21. PubMed ID: 20930312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.
    Moutinho M; Nunes MJ; Gomes AQ; Gama MJ; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Rodrigues E
    Mol Neurobiol; 2015; 51(3):1489-503. PubMed ID: 25084760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.
    Boussicault L; Kacher R; Lamazière A; Vanhoutte P; Caboche J; Betuing S; Potier MC
    Biochimie; 2018 Oct; 153():70-79. PubMed ID: 30107216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.